Carcinoma, Hepatocellular
"Carcinoma, Hepatocellular" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Descriptor ID |
D006528
|
| MeSH Number(s) |
C04.557.470.200.025.255 C04.588.274.623.160 C06.301.623.160 C06.552.697.160
|
| Concept/Terms |
Carcinoma, Hepatocellular- Carcinoma, Hepatocellular
- Carcinomas, Hepatocellular
- Hepatocellular Carcinomas
- Liver Cell Carcinoma, Adult
- Liver Cancer, Adult
- Adult Liver Cancer
- Adult Liver Cancers
- Cancer, Adult Liver
- Cancers, Adult Liver
- Liver Cancers, Adult
- Liver Cell Carcinoma
- Carcinoma, Liver Cell
- Carcinomas, Liver Cell
- Cell Carcinoma, Liver
- Cell Carcinomas, Liver
- Liver Cell Carcinomas
- Hepatocellular Carcinoma
- Hepatoma
- Hepatomas
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Hepatocellular".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Hepatocellular".
This graph shows the total number of publications written about "Carcinoma, Hepatocellular" by people in this website by year, and whether "Carcinoma, Hepatocellular" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 5 | 2 | 7 |
| 1995 | 4 | 5 | 9 |
| 1996 | 4 | 2 | 6 |
| 1997 | 3 | 2 | 5 |
| 1998 | 3 | 5 | 8 |
| 1999 | 4 | 6 | 10 |
| 2000 | 10 | 4 | 14 |
| 2001 | 12 | 2 | 14 |
| 2002 | 21 | 12 | 33 |
| 2003 | 23 | 8 | 31 |
| 2004 | 28 | 7 | 35 |
| 2005 | 28 | 7 | 35 |
| 2006 | 26 | 4 | 30 |
| 2007 | 28 | 4 | 32 |
| 2008 | 32 | 7 | 39 |
| 2009 | 35 | 7 | 42 |
| 2010 | 37 | 8 | 45 |
| 2011 | 32 | 4 | 36 |
| 2012 | 25 | 1 | 26 |
| 2013 | 43 | 1 | 44 |
| 2014 | 33 | 4 | 37 |
| 2015 | 45 | 2 | 47 |
| 2016 | 42 | 3 | 45 |
| 2017 | 42 | 3 | 45 |
| 2018 | 45 | 5 | 50 |
| 2019 | 65 | 4 | 69 |
| 2020 | 70 | 1 | 71 |
| 2021 | 65 | 3 | 68 |
| 2022 | 76 | 1 | 77 |
| 2023 | 71 | 1 | 72 |
| 2024 | 35 | 7 | 42 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Hepatocellular" by people in Profiles.
-
SLC4A11 mediates ammonia import and promotes cancer stemness in hepatocellular carcinoma. JCI Insight. 2024 Nov 08; 9(21).
-
Type I MET inhibitors cooperate with PD-1 blockade to promote rejection of hepatocellular carcinoma. J Immunother Cancer. 2024 Oct 30; 12(10).
-
WNK1 Interaction with KEAP1 Promotes NRF2 Stabilization to Enhance the Oxidative Stress Response in Hepatocellular Carcinoma. Cancer Res. 2024 Sep 04; 84(17):2776-2791.
-
Advanced Imaging of Hepatocellular Carcinoma: A Review of Current and Novel Techniques. J Gastrointest Cancer. 2024 Dec; 55(4):1469-1484.
-
Comparing barriers to early stage diagnosis of hepatocellular carcinoma between safety net hospitals and academic medical centers: An analysis from the United States Safety-Net Collaborative. J Surg Oncol. 2024 Sep; 130(3):493-503.
-
Perioperative outcomes after hepatectomy for hepatocellular carcinoma among patients with cirrhosis, fatty liver disease, and clinically normal livers. Surg Oncol. 2024 Oct; 56:102114.
-
Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial. Clin Mol Hepatol. 2024 Oct; 30(4):807-823.
-
Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001-2020. Cancer Epidemiol. 2024 Oct; 92:102610.
-
SIGLEC15, negatively correlated with PD-L1 in HCC, could induce CD8+ T cell apoptosis to promote immune evasion. Oncoimmunology. 2024; 13(1):2376264.
-
Imageable Radioembolization Microspheres for Treatment of Unresectable Hepatocellular Carcinoma: Interim Results from a First-in-Human Trial. J Vasc Interv Radiol. 2024 Oct; 35(10):1464-1473.e1.